New Results
Chromomycin A2 potently inhibits glucose-stimulated insulin secretion from pancreatic β cells
View ORCID ProfileMichael A Kalwat, In Hyun Hwang, Jocelyn Macho, Magdalena G Grzemska, Jonathan Z Yang, Kathleen McGlynn, View ORCID ProfileJohn B MacMillan, View ORCID ProfileMelanie H Cobb
doi: https://doi.org/10.1101/337113
Michael A Kalwat
1Department of Pharmacology, UT Southwestern Medical Center, Dallas, TX.
In Hyun Hwang
2Department of Pharmacy, Woosuk University, South Korea.
Jocelyn Macho
3Department of Chemistry & Biochemistry, UC Santa Cruz, Santa Cruz, CA
Magdalena G Grzemska
1Department of Pharmacology, UT Southwestern Medical Center, Dallas, TX.
Jonathan Z Yang
1Department of Pharmacology, UT Southwestern Medical Center, Dallas, TX.
Kathleen McGlynn
1Department of Pharmacology, UT Southwestern Medical Center, Dallas, TX.
John B MacMillan
3Department of Chemistry & Biochemistry, UC Santa Cruz, Santa Cruz, CA
Melanie H Cobb
1Department of Pharmacology, UT Southwestern Medical Center, Dallas, TX.
Article usage
Posted July 10, 2018.
Chromomycin A2 potently inhibits glucose-stimulated insulin secretion from pancreatic β cells
Michael A Kalwat, In Hyun Hwang, Jocelyn Macho, Magdalena G Grzemska, Jonathan Z Yang, Kathleen McGlynn, John B MacMillan, Melanie H Cobb
bioRxiv 337113; doi: https://doi.org/10.1101/337113
Subject Area
Subject Areas
- Biochemistry (11718)
- Bioengineering (8724)
- Bioinformatics (29132)
- Biophysics (14936)
- Cancer Biology (12051)
- Cell Biology (17360)
- Clinical Trials (138)
- Developmental Biology (9406)
- Ecology (14146)
- Epidemiology (2067)
- Evolutionary Biology (18269)
- Genetics (12223)
- Genomics (16768)
- Immunology (11844)
- Microbiology (28016)
- Molecular Biology (11560)
- Neuroscience (60822)
- Paleontology (450)
- Pathology (1864)
- Pharmacology and Toxicology (3231)
- Physiology (4940)
- Plant Biology (10401)
- Synthetic Biology (2878)
- Systems Biology (7333)
- Zoology (1642)